Antibody Characterization Report for TATA-binding protein associated factor 2N (TAF15)

In this report, five commercial antibodies against TATA-binding protein associated factor 2N (TAF15) were characterized for use Western Blot, immunoprecipitation, and immunofluorescence, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. 

This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP), established as a public-private partnership by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.